Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Immunoglobulin Light-chain Amyloidosis 2Amyloidosis 2Waldenstrom Macroglobulinemia 1Polycystic Ovary Syndrome 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Menstruation Disturbances 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hyperandrogenism 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Amyloidosis, Familial 1Advanced Malignant Neoplasm 1AA amyloidosis 1

Interventions

Dexamethasone 9Calcium Dobesilate 7Bortezomib 5Melphalan 4Cyclophosphamide 3ixazomib 2Thalidomide 2Doxycycline 2dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1carfilzomib 1birtamimab 1auricularum 1Tacrolimus 1Lenalidomide 1Etoposide 1Doxorubicin 1Cisplatin 1Bendamustine Hydrochloride 1Antilymphocyte Serum 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Amyloidosis × Doxycycline × Clear all
NCT02207556 2021-07-09

DUAL

Medical College of Wisconsin

Phase 2 Completed
32 enrolled 15 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01677286 2017-08-01

Safety and Effect of Doxycycline in Patients With Amyloidosis

Boston University

Phase 2 Completed
25 enrolled 13 charts
Plasma cell

AA amyloidosis, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Amyloidosis, Familial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡